We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
-4.2%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$153M
AUM Growth
-$12.1M
Cap. Flow
-$1.82M
Cap. Flow %
-1.19%
Top 10 Hldgs %
21.35%
Holding
258
New
56
Increased
66
Reduced
77
Closed
59

Top Buys

Rank Stock Value
1
LAZ icon
Lazard
LAZ
+$1.25M
2
GILD icon
Gilead Sciences
GILD
+$1.17M
3
EIX icon
Edison International
EIX
+$1.14M
4
AMGN icon
Amgen
AMGN
+$1.12M
5
CSCO icon
Cisco
CSCO
+$963K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.41M
2
HPQ icon
HP
HPQ
+$1.91M
3
MPC icon
Marathon Petroleum
MPC
+$1.47M
4
DUK icon
Duke Energy
DUK
+$1.36M
5
JEF icon
Jefferies Financial Group
JEF
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 19.11%
2 Healthcare 16.75%
3 Financials 16.1%
4 Consumer Discretionary 8.77%
5 Communication Services 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOYA icon
251
Voya Financial
VOYA
$9.23B
-4,230
Closed -$252K
VST icon
252
Vistra
VST
$48.5B
-7,095
Closed -$162K
VTRS icon
253
Viatris
VTRS
$19B
-11,120
Closed -$116K
WLK icon
254
Westlake Corp
WLK
$10B
-1,275
Closed -$125K
WRB icon
255
W.R. Berkley
WRB
$26.2B
-3,725
Closed -$169K
WTFC icon
256
Wintrust Financial
WTFC
$10.7B
-1,560
Closed -$125K
VRTV
257
DELISTED
VERITIV CORPORATION
VRTV
-2,048
Closed -$222K
UNVR
258
DELISTED
Univar Solutions Inc.
UNVR
-5,800
Closed -$144K

Similar funds

Convergence Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Convergence Investment Partners held 258 positions worth $153M, down 7.3% from $165M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Convergence Investment Partners's Q3 2022 filing shows 56 new, 66 increased, 77 reduced and 59 closed positions. Its largest new stake was Lazard: 34,896 shares worth $1.11M. The largest sale was Pfizer, an estimated $2.41M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Convergence Investment Partners's largest Q3 2022 buy was Lazard: 34,896 shares worth $1.11M.
  • Convergence Investment Partners added most to Gilead Sciences in Q3 2022, an estimated $1.17M increase.
  • Convergence Investment Partners's biggest Q3 2022 reduction was Pfizer, cutting an estimated $2.41M.
  • Convergence Investment Partners fully exited HP in Q3 2022, selling an estimated $1.91M.
  • Convergence Investment Partners's ten largest holdings make up 21% of its $153M portfolio in Q3 2022.
  • Convergence Investment Partners opened 56 new positions and closed 59 in Q3 2022.
  • Convergence Investment Partners's portfolio value fell 7.3% quarter-over-quarter to $153M.

Based on Convergence Investment Partners's 13F filing for Q3 2022, filed 8 Nov 2022.